Alert: New Earnings Report (2/26/24)-Theravance Biopharma Inc (NASDAQ: TBPH).
For its fourth fiscal quarter (ending December 31), Theravance Biopharma Inc (NASDAQ: TBPH) has reported E.P.S. of $-0.17 compared to $-0.21 a year ago. This result fell short of the consensus estimate of $-0.00 by […]